2023 annual financial data
Regencell Bioscience 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -6,273,671 USD and net income was -5,871,130 USD.
Operating cash flow was -4,962,949 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,273,671 USD
- Net income
- -5,871,130 USD
- Operating cash flow
- -4,962,949 USD